Viewing Study NCT01092858


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-01-06 @ 9:27 PM
Study NCT ID: NCT01092858
Status: TERMINATED
Last Update Posted: 2014-11-05
First Post: 2010-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypogonadism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Testosterone undecanoate View
None Hypogonadism View